Gilde Healthcare Partners
ALGEMENE INFORMATIE
Bezoekadres
Newtonlaan 91
3584 BP Utrecht
Postadres
Postbus 85067
3508 AB Utrecht
Tel: +31 30 219 25 36
Fax: +31 30 219 25 96 Contactpersoon
Pascale Albers
Directie
De heer P. H. van der Meer
Newtonlaan 91
3584 BP Utrecht
Postadres
Postbus 85067
3508 AB Utrecht
Tel: +31 30 219 25 36
Fax: +31 30 219 25 96 Contactpersoon
Pascale Albers
Directie
De heer P. H. van der Meer
Gilde Healthcare Partners (Utrecht, The Netherlands and Cambridge, USA) is a transatlantic venture and growth capital firm focused on private healthcare technology and service companies.
It has over €450 million ($600 million) under management and is actively looking to lead new investments in diagnostics, medical devices, therapeutics and healthcare services.
Gilde succesfully builds healthcare businesses acros Europe and US, investing up to €15 million ($20 million) in a single portfolio company.
Much of Gilde’s excellent market position and proven track record can be attributed to its people: an international team of investment professionals with successful track records in private equity, operations, M&A, corporate finance, strategy consultancy and extensive experience in the various Healthcare sectors.
It has over €450 million ($600 million) under management and is actively looking to lead new investments in diagnostics, medical devices, therapeutics and healthcare services.
Gilde succesfully builds healthcare businesses acros Europe and US, investing up to €15 million ($20 million) in a single portfolio company.
Much of Gilde’s excellent market position and proven track record can be attributed to its people: an international team of investment professionals with successful track records in private equity, operations, M&A, corporate finance, strategy consultancy and extensive experience in the various Healthcare sectors.
PROFIEL
- Sectoren/branches
- Anders
- Handel & Dienstverlening
- Life Sciences
- Financieringsfasen
- Expansie
- Seed
- Start
- Investering
- 2 mln - 5 mln
- 5 mln - 20 mln
- 20+ mln
- Regio's
- Benelux
- Duitsland
- Europa
- Nederland (excl. regionale focus)
- Verenigde Staten
- Belegger in fonds
- Banken
- Overig
- Pensioenfondsen
- Verzekeringsmaatschappijen
INVESTERINGEN
| bedrijf | jaar | sector | fase |
|---|---|---|---|
| IDEA | 1995 | Pain Management | Growth |
| Pieris | 2002 | Protein Therapeutics | Start |
| Agendia | 2004 | Genomic profiling | Start |
| Chroma Therapeutics | 2004 | Chromatin biology use in cancer drug discovery | Start |
| Conatus Pharmaceuticals | 2006 | Inflammation and liver disease drug development | Start |
| Ascendis Pharma | 2007 | Drug improvement | Growth |
| Santaris Pharma | 2007 | Oligonucleotide drugs based on the company’s proprietary, 3rd generation RNA analogue | Start |
| Symphogen | 2007 | Polyclonal Antibody Therapeutics | Start |
| Acacia Pharma | 2008 | Hospital based pharmaceutical business based on products targeting the secondary care market in oncology and peri-operative care | Growth |
| ProFibrix | 2009 | Fibrinogen technology | Growth |
| InovaLabs | 2011 | Portable oxygen concentrator for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) | Start |
| Moximed | 2011 | Osteoarthritis drug and care development | Start |
| Prosonix | 2011 | Mono and combination respiratory medicines | Start |
